03:25 GMT14 August 2020
Listen Live
    Get short URL
    Global COVID-19 Cases Spike to Highest Level Post-Lockdown (92)
    0 447

    NIZHNY NOVGOROD (Sputnik) - Clinical trials of a COVID-19 vaccine, developed by the Gamaleya Institute of Epidemiology and Microbiology, have been completed, Russian Minister of Health Mikhail Murashko said.

    "The vaccine against coronavirus infection, developed by the Gamaleya Institute, has completed clinical trials," Murashko told reporters, answering a question about whether the clinical trials of the vaccine are officially completed.

    Murashko also said that the health ministry expects at least two requests to begin clinical trials in the coming two months.

    “We expect at least two more applications in the next one and a half to two months for permission to conduct clinical trials," Murashko said.

    He noted that the packet of documents for vaccine registration is being prepared.

    Global COVID-19 Cases Spike to Highest Level Post-Lockdown (92)
    COVID-19, vaccine, Russia
    Community standardsDiscussion